Celltrion Holdings IPO

Youngone Corp., a South Korean outdoor clothing maker to global brands like The North Face and Patagonia, has given a clearer signal that Chairman...

A Morgan Stanley-affiliated asset manager has bought more JYP Entertainment shares, raising its stake to more than 5 percent.Asset management firm M...

Global ice cream chain Baskin-Robbins, the top ice cream seller in South Korea, is solidifying its market position with localization despite the cou...

South Korea's POSCO Holdings Inc. has returned to the level of 1 trillion won ($790.5 million) in quarterly operating profit after a year and sales ...

Global top ultracapacitor player LS Materials Co. is expected to go public in South Korea this year, which would mark the first LS Group company IPO...

SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), is set to raise $500 millio...

South Korea’s Kakao Pay Corp. announced on Friday that it has prepared a large-scale discount promotion in collaboration with PayPay, the top ...

South Korea’s initial public offering market is heating up with some 30 firms set for new share subscriptions in July and August, more than su...

Macquarie Asset Management is aiming to close its sixth buyout fund in South Korea at a maximum of 1 trillion won ($775.6 million) by the first ha...

National Pension Service (NPS) of South Korea, the world’s third-largest pension fund with 975.6 trillion won ($754.2 billion) in assets under...

Samsung Electronics Co. and SK Hynix Inc. – the world’s two largest memory chipmakers – have fiercely competed to advance their ch...

South Korea’s No. 1 biopharmaceutical company Samsung BioLogics Co. and No. 2 Celltrion Inc. produced higher CO2 emissions last year than in 2...

South Korea's regenerative medicine company T&R Biofab Co. on Monday said it obtained a patent in Japan for production technology for liver or...

South Korean biopharmaceutical company Celltrion Healthcare on Monday said it launched the day before on the US market Yuflyma, a biosimilar of the ...

South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...

Samsung Electronics Co. on Tuesday launched its three-day global strategy meeting, a biannual event held in June and December where major executives...

South Korea’s Celltrion Inc. has put its Japanese Takeda Pharmaceutical Co.'s primary care assets acquired in 2020 on sale as the biosimilar g...

South Korea's KakaoBank Corp. has begun its advance into Southeast Asia through a tie-up with a financial company in Thailand. KakaoBank on Friday ...

GS Engineering & Construction Co. announced on Friday that it recently held the “1st Global HR Leaders Conference” attended by chief...

South Korea's biopharmaceutical company Celltrion Inc. announced that it received on Thursday approval from the US Food and Drug Administration (FDA...

Invest Korea, KOTRA's organization dedicated to attracting foreign investment, held an IR for Japanese companies interested in entering South Korea ...

A large-scale business event was held in Dubai to support the expansion of Korean small- and medium-sized enterprises (SMEs) into the Middle East.Th...

South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it plans to beef up its portfolio by applying for regulatory approv...

South Korean battery maker SK On Co. has secured $400 million from Hillhouse, a Singapore-headquartered asset management firm, investment banking so...

Air Premia Inc., a South Korean low-cost carrier (LCC) that was established in 2017 and started flight operations last July, is gearing for fast gro...

South Korea's biopharmaceutical company Celltrion Inc. announced on Monday that it has signed a contract with the US biotech firm Rani Therapeutics ...

South Korea's anemic initial public offering market has forced the country’s startups to become more creative in raising funds as they shift t...

MILAN – South Korea's biopharmaceutical company Celltrion Inc. is known in Europe for its biosimilar products such as autoimmune disease treat...

South Korean biosimilar giant Celltrion Inc. revealed on Wednesday the highly anticipated clinical phase 1 data for its Actemra biosimilar, CT-P47, ...

More than 500 South Korean companies from top business groups to AI-based biotech startups are slated to attend the Bio International Convention 202...